Toprel

Toprel may be available in the countries listed below.

Ingredient matches for Toprel

Topiramate

Topiramate is reported as an ingredient of Toprel in the following countries:

• Chile

International Drug Name Search

Proscar

Proscar is a brand name of finasteride, approved by the FDA in the following formulation(s):

PROSCAR (finasteride - tablet; oral)

• 
  Manufacturer: MERCK
  
  Approval date: June 19, 1992
  
  Strength(s): 5MG ^[RLD][AB]

Has a generic version of Proscar been approved?

A generic version of Proscar has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Proscar and have been approved by the FDA:

finasteride tablet; oral

• 
  Manufacturer: ACCORD HLTHCARE INC
  
  Approval date: February 23, 2010
  
  Strength(s): 5MG ^[AB]


• 
  Manufacturer: ACTAVIS TOTOWA
  
  Approval date: March 28, 2007
  
  Strength(s): 5MG ^[AB]


• 
  Manufacturer: AUROBINDO PHARMA
  
  Approval date: October 30, 2007
  
  Strength(s): 5MG ^[AB]


• 
  Manufacturer: DR REDDYS LABS LTD
  
  Approval date: February 28, 2007
  
  Strength(s): 5MG ^[AB]


• 
  Manufacturer: GEDEON RICHTER USA
  
  Approval date: December 22, 2006
  
  Strength(s): 5MG ^[AB]


• 
  Manufacturer: HETERO DRUGS LTD
  
  Approval date: June 7, 2010
  
  Strength(s): 5MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: December 18, 2006
  
  Strength(s): 5MG ^[AB]


• 
  Manufacturer: SUN PHARMA GLOBAL
  
  Approval date: August 16, 2011
  
  Strength(s): 5MG ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: December 15, 2006
  
  Strength(s): 5MG ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA INC
  
  Approval date: December 28, 2009
  
  Strength(s): 5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Proscar. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Finasteride processes
  Patent 5,886,184
  Issued: March 23, 1999
  Inventor(s): Dolling; Ulf H. & McCauley; James A. & Varsolona; Richard J.
  Assignee(s): Merck & Co., Inc.
  Disclosed is a new process for producing finasteride which involves reacting the magnesium halide salt of 17.beta.-carboalkoxy-4-aza-5.alpha.-androst-1-en-3-one with t-butylamino magnesium halide, present in at least a 2:1 molar ratio to the ester, formed from t-butyl amine and an aliphatic/aryl magnesium halide at ambient temperature in an inert organic solvent under an inert atmosphere followed by heating and recovering the product finasteride. Also disclosed are two polymorphic crystalline Forms I and II of finasteride, and methods of their production.
  
  Patent expiration dates:
  
  
  • November 19, 2012
    
    ✓ 
    Drug substance
  
  



• 
  Prevention of precipitated acute urinary retention
  Patent 5,942,519
  Issued: August 24, 1999
  Inventor(s): Waldstreicher; Joanne
  Assignee(s): Merck & Co., Inc.
  This invention is concerned with the prevention of precipitated acute urinary retention in a subject male susceptible thereto by the administration of an inhibitor of 5.alpha.-reductase to the subject. The present invention also provides for a method of reducing the risk of precipitated acute urinary retention by the administration of a 5.alpha.-reductase inhibitor to the subject at risk therefor.
  
  Patent expiration dates:
  
  
  • October 23, 2018
    
    ✓ 
    Patent use: TREATING PRECIPITATED ACUTE URINARY RETENTION WITH FINASTERIDE
  
  

See also...

• Proscar Consumer Information (Drugs.com)
• Proscar Consumer Information (Wolters Kluwer)
• Proscar Consumer Information (Cerner Multum)
• Proscar Advanced Consumer Information (Micromedex)
• Finasteride Consumer Information (Wolters Kluwer)
• Finasteride Consumer Information (Cerner Multum)
• Finasteride Advanced Consumer Information (Micromedex)
• Finasteride AHFS DI Monographs (ASHP)

Nazene Z

Nazene Z may be available in the countries listed below.

Ingredient matches for Nazene Z

Oxymetazoline

Oxymetazoline hydrochloride (a derivative of Oxymetazoline) is reported as an ingredient of Nazene Z in the following countries:

• South Africa

Zinc Sulfate

Zinc Sulfate is reported as an ingredient of Nazene Z in the following countries:

• South Africa

International Drug Name Search

Duramorph PF

Duramorph PF is a brand name of morphine, approved by the FDA in the following formulation(s):

DURAMORPH PF (morphine sulfate - injectable; injection)

• 
  Manufacturer: BAXTER HLTHCARE
  
  Approval date: September 18, 1984
  
  Strength(s): 0.5MG/ML ^[RLD][AP], 1MG/ML ^[RLD][AP]

Has a generic version of Duramorph PF been approved?

Yes. The following products are equivalent to Duramorph PF:

ASTRAMORPH PF (morphine sulfate injectable; injection)

• 
  Manufacturer: APP PHARMS
  
  Approval date: October 7, 1986
  
  Strength(s): 0.5MG/ML ^[AP], 0.5MG/ML ^[AP], 1MG/ML ^[AP], 1MG/ML ^[AP]

morphine sulfate injectable; injection

• 
  Manufacturer: HOSPIRA
  
  Approval date: May 11, 1988
  
  Strength(s): 0.5MG/ML ^[AP], 1MG/ML ^[AP]


• 
  Manufacturer: HOSPIRA
  
  Approval date: September 30, 1992
  
  Strength(s): 0.5MG/ML ^[AP], 1MG/ML ^[AP]


• 
  Manufacturer: WATSON LABS
  
  Approval date: September 30, 1991
  
  Strength(s): 0.5MG/ML ^[AP], 0.5MG/ML ^[AP], 1MG/ML ^[AP], 1MG/ML ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Duramorph PF. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Duramorph PF.

See also...

• Morphine Consumer Information (Drugs.com)
• Morphine Concentrate Consumer Information (Wolters Kluwer)
• Morphine Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Morphine Immediate-Release Consumer Information (Wolters Kluwer)
• Morphine Immediate-Release Tablets Consumer Information (Wolters Kluwer)
• Morphine Soluble Tablets Consumer Information (Wolters Kluwer)
• Morphine Solution Consumer Information (Wolters Kluwer)
• Morphine Suppositories Consumer Information (Wolters Kluwer)
• Morphine Sustained-Release Tablets Consumer Information (Wolters Kluwer)
• Morphine IR Consumer Information (Cerner Multum)
• Morphine Consumer Information (Cerner Multum)
• DepoDur Advanced Consumer Information (Micromedex)
• Morphine Advanced Consumer Information (Micromedex)
• Morphine Epidural Advanced Consumer Information (Micromedex)
• Morphine Injection Advanced Consumer Information (Micromedex)
• Morphine Sulfate AHFS DI Monographs (ASHP)

Natrij-hidrogenkarbonat

Natrij-hidrogenkarbonat may be available in the countries listed below.

Ingredient matches for Natrij-hidrogenkarbonat

Sodium Bicarbonate

Sodium Bicarbonate is reported as an ingredient of Natrij-hidrogenkarbonat in the following countries:

• Croatia (Hrvatska)

International Drug Name Search

Bisacodyl Teva

Bisacodyl Teva may be available in the countries listed below.

Ingredient matches for Bisacodyl Teva

Bisacodyl

Bisacodyl is reported as an ingredient of Bisacodyl Teva in the following countries:

• Belgium

International Drug Name Search

Femigyne-ratiopharm

Femigyne-ratiopharm may be available in the countries listed below.

Ingredient matches for Femigyne-ratiopharm

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Femigyne-ratiopharm in the following countries:

• Germany

Levonorgestrel

Levonorgestrel is reported as an ingredient of Femigyne-ratiopharm in the following countries:

• Germany

International Drug Name Search

Acnestop

Acnestop may be available in the countries listed below.

Ingredient matches for Acnestop

Clindamycin

Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of Acnestop in the following countries:

• Argentina

International Drug Name Search

Lisinopril Acost

Lisinopril Acost may be available in the countries listed below.

Ingredient matches for Lisinopril Acost

Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril Acost in the following countries:

• Spain

International Drug Name Search

Sintocin

Sintocin may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Sintocin

Oxytocin

Oxytocin is reported as an ingredient of Sintocin in the following countries:

• Italy

International Drug Name Search

Euchessina CM

Euchessina CM may be available in the countries listed below.

Ingredient matches for Euchessina CM

Sodium Picosulfate

Sodium Picosulfate is reported as an ingredient of Euchessina CM in the following countries:

• Italy

International Drug Name Search